Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: A two-year randomized, placebo-controlled study
article
OA: closed
CC0
⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This randomized, placebo-controlled study investigated the effects of two tibolone doses on bone loss in early postmenopausal women over two years.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (1)
References (32)
- The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl) via openalex
- W143921209 via openalex
- W1771039750 via openalex
- W1966019630 via openalex
- W1967461894 via openalex
- W1968418396 via openalex
- W1983294487 via openalex
- W2002924549 via openalex
- W2007220536 via openalex
- W2007741627 via openalex
- W2008816153 via openalex
- W2023173649 via openalex
- W2030908961 via openalex
- W2038033023 via openalex
- W2047366838 via openalex
- W2052998518 via openalex
- W2058585863 via openalex
- W2068523275 via openalex
- W2072427778 via openalex
- W2081496304 via openalex
- W2087360583 via openalex
- W2110032816 via openalex
- W2154542408 via openalex
- W2157317148 via openalex
- W2162402859 via openalex
- W2293614518 via openalex
- W2520711784 via openalex
- W2917532995 via openalex
- W4252543199 via openalex
- W6605802734 via openalex
- W91497135 via openalex
- W6637954398 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK